Rick E. Winningham, a director at Jazz Pharmaceuticals plc ($JAZZ), made one open market sale of company shares in the last year, totaling nearly $1 million. His most recent sale occurred on November 18, 2025. These sales rank 4,949th among 11,678 individual insiders in our database, where the average is $8.6 million across about six transactions. Winningham reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 75000 | $0.00 | 1,767,061.0000 | 51,507,000 | 4.43% | 0.15% |
| Feb. 20, 2026 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 74975 | $19.66 | 1,692,061.0000 | 51,908,000 | 4.24% | 0.14% |
| Nov. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 56817 | $17.90 | 1,767,036.0000 | 51,908,000 | 3.12% | 0.11% |
| Nov. 19, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 9900 | $0.00 | 1,767,036.0000 | 51,908,000 | 0.56% | 0.02% |
| Nov. 19, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 9900 | $0.00 | 1,823,853.0000 | 51,908,000 | 0.54% | 0.02% |
| Nov. 18, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Winningham Rick E | Director | S | Ordinary Shares | 5500 | $180.86 | 8,893.0000 | 61,606,000 | 38.21% | 0.01% |
| Aug. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 15394 | $13.39 | 1,823,853.0000 | 50,726,000 | 0.84% | 0.03% |
| Aug. 8, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Winningham Rick E | Director | F | Ordinary Shares | 1805 | $111.25 | 14,393.0000 | 66,007,000 | 11.14% | 0.00% |
| Aug. 7, 2025 | Jazz Pharmaceuticals plc | $JAZZ | Winningham Rick E | Director | A | Ordinary Shares | 3507 | $0.00 | 16,198.0000 | 66,007,000 | 27.63% | 0.01% |
| June 23, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 20000 | $0.00 | 1,839,247.0000 | 49,706,000 | 1.08% | 0.04% |
| June 13, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 9600 | $0.00 | 1,859,247.0000 | 49,706,000 | 0.52% | 0.02% |
| June 13, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 9600 | $0.00 | 1,859,247.0000 | 49,706,000 | 0.51% | 0.02% |
| May 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 15364 | $9.45 | 1,859,247.0000 | 49,706,000 | 0.82% | 0.03% |
| Feb. 28, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 2178 | $9.35 | 1,874,611.0000 | 48,847,000 | 0.12% | 0.00% |
| Feb. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 35129 | $9.66 | 1,872,433.0000 | 48,847,000 | 1.84% | 0.07% |
| Nov. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 15997 | $9.97 | 1,907,562.0000 | 49,038,000 | 0.83% | 0.03% |
| Nov. 14, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 3193 | $9.57 | 1,923,559.0000 | 49,038,000 | 0.17% | 0.01% |
| Aug. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 15997 | $8.22 | 1,920,366.0000 | 48,747,000 | 0.83% | 0.03% |
| Aug. 7, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 3252 | $7.83 | 1,936,363.0000 | 48,747,000 | 0.17% | 0.01% |
| Aug. 2, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Winningham Rick E | Director | A | Ordinary Shares | 3731 | $0.00 | 14,175.0000 | 72,066,000 | 35.72% | 0.01% |
| Aug. 6, 2024 | Jazz Pharmaceuticals plc | $JAZZ | Winningham Rick E | Director | F | Ordinary Shares | 1484 | $111.35 | 12,691.0000 | 72,066,000 | 10.47% | 0.00% |
| May 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 15997 | $9.10 | 1,933,111.0000 | 48,283,000 | 0.82% | 0.03% |
| May 15, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 2068 | $9.85 | 1,949,108.0000 | 48,283,000 | 0.11% | 0.00% |
| April 2, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 300000 | $0.00 | 1,947,040.0000 | 48,283,000 | 18.21% | 0.62% |
| March 15, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 3900 | $0.00 | 1,647,040.0000 | 55,303,000 | 0.24% | 0.01% |
| March 15, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 7000 | $0.00 | 1,650,940.0000 | 55,303,000 | 0.42% | 0.01% |
| March 15, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | A | Ordinary Shares | 2704 | $8.64 | 1,657,940.0000 | 55,303,000 | 0.16% | 0.00% |
| March 15, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | G | Ordinary Shares | 3900 | $0.00 | 1,647,040.0000 | 55,303,000 | 0.24% | 0.01% |
| Feb. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Winningham Rick E | CHIEF EXECUTIVE OFFICER | F | Ordinary Shares | 37196 | $8.92 | 1,651,336.0000 | 55,303,000 | 2.20% | 0.07% |
| Aug. 14, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Winningham Rick E | Director | S | Ordinary Shares | 1241 | $138.16 | 10,444.0000 | 62,539,000 | 10.62% | 0.00% |
| Aug. 11, 2023 | Jazz Pharmaceuticals plc | $JAZZ | Winningham Rick E | Director | A | Ordinary Shares | 3075 | $0.00 | 11,685.0000 | 62,539,000 | 35.71% | 0.00% |